Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-25T09:04:06.516Z Has data issue: false hasContentIssue false

Lipids and schizophrenia

Published online by Cambridge University Press:  03 January 2018

D. F. Horrobin*
Affiliation:
Laxdale Research, Kings Park House, Laurelhill Business Park, Stirling FK7 9JQ
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Copyright
Copyright © 1999 The Royal College of Psychiatrists 

References

Horrobin, D. F. (1998) The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophrenia Research, 30, 193208.Google Scholar
Horrobin, D. F. (1999) Phospholipid metabolism and schizophrenia. Schizophrenia Research, 36, 105106.Google Scholar
Piccini, M., Vitelli, F., Bruttini, M., et al (1998) FACL4, a new gene encoding long-chain acyl-CoA synthetase 4, is deleted in a family with Alport syndrome, elliptocytosis. and mental retardation. Genomics, 47, 350358.Google Scholar
Ross, B. M., Hudson, C., Erlich, J., et al (1997) Increased phospholipid breakdown in schizophrenia – evidence for the involvement of a calcium-independent phospholipase A(2). Archives of General Psychiatry, 54, 487494.Google Scholar
Vial, D. & Piomelli, D. (1995) Dopamine D2-receptors potentiate arachidonate release via activation of cytosolic, arachidonate-specific phospholipase A2 . Journal of Neurochemistry, 64, 27652772.Google Scholar
Walker, N. P., Fox, H. C. & Walley, L. J. (1999) Lipids and schizophrenia. British Journal of Psychiatry, 174, 101104.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.